MedPath

The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance

Phase 2
Conditions
Lung Disease
Registration Number
NCT01090804
Lead Sponsor
Khon Kaen University
Brief Summary

The purpose of this study is to determined effects of BreatheMAX on secretion clearance.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
14
Inclusion Criteria
  • One sign of secretion accumulation in bronchi
  • Stable cardiopulmonary function
  • Good consciousness and good co-operation
Exclusion Criteria
  • Massive hemoptysis
  • Pneumothorax (untreated)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
secretion wet weight (gram)Three hours before, ten hours after treatment and night-time (02.00-07.00 am.)

Airway mucus secretion was collected for three hours before and ten hours after treatment based on an auditory airway secretion sound and collected again at 02.00-07.00 am.The mucus secretion was collected by sterile suctioning technique via tracheostomy tube without adding any saline or sterile water.

viscosity of secretionThree hours before and after treatment

The secretion were collected in three hours before and after treatment, It were measured viscosity by First The mucus was gently homogenized by tissue grinder 5 ml (Cw11-205, Cowie, UK) for six minute at 37 degree celsius Second using Micro-Oswald viscometers with a capillary diameter of 0.77 mm for viscosity measure at same temperature in each sample(before and after).

Secondary Outcome Measures
NameTimeMethod
Oxygen saturation (%SpO2)Before, during breathing exercise with device and immediate after treatment

Oxygen saturation was monitored before, during and immediate after breathing exercise with BreatheMAX (6-10 beats/set, 10 set/day and rest between set for 1 minute)

Heart rate (beat/min)Before, during breathing exercise with device and immediate after treatment

Heart rate was monitored before, during and immediate after breathing exercise with BreatheMAX (6-10 beats/set, 10 set/day and rest between ste for 1 minute)

Respiratory rate (times/min)In rest interval between set (1 minute)

Respiratory rate was measured by manual for 1 minute before, rest interval between set and immediate after breathing exercise with device (during the patients reconnection mechanical ventilation)

Trial Locations

Locations (1)

Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen University

🇹🇭

Muang, Khon Kaen, Thailand

Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen University
🇹🇭Muang, Khon Kaen, Thailand
Sujittra Kluayhomthong, Bachelor
Contact
668-139-0647
rabbit_tigger@hotmail.com
Chulee CU Jones, Philosophy
Contact
664-320-2399
chujones46@yahoo.co.uk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.